Hyderabad-based Dr. Reddy's Laboratories had presented its proposal to DCGI for conducting the phase-3 trial of Sputnik Light vaccine as booster dose.
Only about 43% of the country's 12.6 million inhabitants over age 11 are fully vaccinated, in a country whose total population is 17 million.
While Sputnik V has already received regulatory approval, Dr Reddy's Laboratory received the Drugs Controller General of India (DGCI) nod to conduct phase-3...
The Russian capital has ordered the 11-day closing of all non-essential businesses and schools. Thursday saw new record Covid-19 case numbers and deaths.
The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.
Dr Reddy's soft launched the vaccine in India in May 2021, after receiving Emergency Use Authorization (EUA) in April 2021.
The Russian Direct Investment Fund (RDIF), which launched the Sputnik V Covid-19 vaccine, has a tie up with Dr Reddy’s Laboratories to sell the vaccines in...
As many as 300 million doses of Sputnik V will be manufactured by Serum Institute of India every year, the Russian Direct Investment Fund (RDIF) said
Dr Reddy's recently received nearly three million doses of Sputnik V from Russian Direct Investment Fund
There is no scientific data so far to establish that the Delta Plus Covid variant is highly transmissible or reduces vaccine efficacy, India’s Covid Task...
The offer is available to vaccinated passengers aged 18 years and above, who are located in India
Slovakia has 200,000 doses of the Sputnik V vaccine available now
According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially.
Serum Institute of India has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its...
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India.
Delhi CM Arvind Kejriwal made the announcement while launching a free of cost vaccination drive for journalists and their families
Panacea Biotech is expected to produce 100 million doses of Russia’s Sputnik V Covid-19 vaccine every year.
The Delhi High Court rapped the Centre on Tuesday for not facilitating the manufacturing of Sputnik V vaccines in India